Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plavix Injunction Ruling Will Include Irreparable Harm Interpretation

This article was originally published in The Pink Sheet Daily

Executive Summary

If a preliminary injunction is granted, Apotex says it would suffer irreparable harm of $4 bil.; Sanofi/Bristol counter it would be only $25 mil.
Advertisement

Related Content

Plavix "Irreparable Harm" Debated During Preliminary Injunction Appeal
Plavix "Irreparable Harm" Debated During Preliminary Injunction Appeal
Plavix Generic Faces Injunction, But Not Recall
Plavix Generic Faces Injunction, But Not Recall
Cephalon Provigil Generics Settlements Under FTC Investigation
Cephalon Provigil Generics Settlements Under FTC Investigation
Plavix Scripts Fall To 35% On Heels Of Generic Entry
Apotex Seeks $4 Bil. Bond From Sanofi/Bristol At Plavix Injunction Hearing
Plavix Hearing Scheduled For Aug. 18 After Sanofi/Bristol File Preliminary Injunction
Plavix Hearing Scheduled For Aug. 18 After Sanofi/Bristol File Preliminary Injunction

Topics

Advertisement
UsernamePublicRestriction

Register

PS064719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel